Changseon Ryu

Dr. Changseon Ryu

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2014 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
JCJong Min Choi
Jong Min Choi
SOSoo Jin Oh
Soo Jin Oh
SLSang Yoon Lee
Sang Yoon Lee
JIJi Hye Im
Ji Hye Im
JOJung Min Oh
Jung Min Oh
SKSang Kim
Sang Kim

1 November 2009 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
HCHoo-Kyun Choi
Hoo-Kyun Choi
YPYuba Raj Pokharel
Yuba Raj Pokharel
SLSung Chul Lim
Sung Chul Lim
HHHyo-Kyung Han
Hyo-Kyung Han
CRChangseon Ryu
Changseon Ryu
KKKeon Wook Kang
Keon Wook Kang

27 March 2017 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
CRChangseon Ryu
Changseon Ryu
KKKathrin Klein
Kathrin Klein
UZUlrich M. Zanger
Ulrich M. Zanger
Membrane-associated progesterone receptors (MAPR) are a group of four rather small, partially homologous proteins, which share a similar non-covalent heme-binding domain that is related to cytochrome b5, a well-known functional interaction partner of microsomal cytochrome P450 (CYP) monooxygenase systems. Apart from their structural similarities the four proteins progesterone membrane component 1 (PGRMC1, also referred to as IZA, sigma-2 receptor, Dap1), PGRMC2, neudesin (NENF) and neuferricin (CYB5D2) display surprisingly divergent and multifunctional physiological properties related to cholesterol/steroid biosynthesis, drug metabolism and response, iron homeostasis, heme trafficking, energy metabolism, autophagy, apoptosis, cell cycle regulation, cell migration, neural functions, and tumorigenesis and cancer progression. The purpose of this mini-review is to briefly summarize the structural and functional properties of MAPRs with particular focus on their interactions with the CYP system. For PGRMC1, originally identified as a non-canonical progesterone-binding protein that mediates some immediate non-genomic actions of progesterone, available evidence indicates mainly activating interactions with steroidogenic CYPs including CYP11A1, CYP21A2, CYP17, CYP19, CYP51A1, and CYP61A1, while interactions with drug metabolizing CYPs including CYP2C2, CYP2C8, CYP2C9, CYP2E1, and CYP3A4 were either ineffective or slightly inhibitory. For the other MAPRs the evidence is so far less conclusive. We also point out that experimental limitations question some of the previous conclusions. Use of appropriate model systems should help to further clarify the true impact of these proteins on CYP-mediated metabolic pathways.

1 May 2012 in Food Chemistry
Verified
Journal Article
Closed access
CRChangseon Ryu
Changseon Ryu
CKChung Hyeon Kim
Chung Hyeon Kim
SLSang Yoon Lee
Sang Yoon Lee
KLKye Sook Lee
Kye Sook Lee
KCKyu Jin Choung
Kyu Jin Choung
SKSang Kim
Sang Kim

1 April 2020 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
CPChang Gyun Park
Chang Gyun Park
BSBaeckkyoung Sung
Baeckkyoung Sung
CRChangseon Ryu
Changseon Ryu
YKYoungjun Kim
Youngjun Kim

1 June 2009 in Journal of Hepatology
Verified
Journal Article
Closed access
SKSun J. Kim
Sun J. Kim
JLJoo W. Lee
Joo W. Lee
YJYoung S. Jung
Young S. Jung
DKDo Y. Kwon
Do Y. Kwon
HPHee K. Park
Hee K. Park
YKYoung C. Kim
Young C. Kim